Significant data integrity violations were found at the Zhejiang facility of NingBo Huize Commodity Co., according to a warning letter FDA sent to the company on Aug. 2, 2019. According to FDA, during the inspection, which occurred from March 18 22, 2019, the company s quality staff admittedOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.